|
Originally published In Press as doi:10.1074/jbc.M200203200 on March 21, 2002
J. Biol. Chem., Vol. 277, Issue 23, 21086-21094, June 7, 2002
Purification and Characterization of a Cytosolic, 42-kDa and
Ca2+-dependent Phospholipase A2
from Bovine Red Blood Cells
ITS INVOLVEMENT IN Ca2+-DEPENDENT RELEASE OF
ARACHIDONIC ACID FROM MAMMALIAN RED BLOOD CELLS*
Hae Sook
Shin **,
Mi-Reyoung
Chin ,
Jung Sun
Kim ,
Jin-Ho
Chung§,
Chung-Kyu
Ryu¶,
Sung Yun
Jung , and
Dae Kyong
Kim
From the Department of Environmental & Health
Chemistry, College of Pharmacy, Chung-Ang University, Dongjak-Ku, Seoul
156-756, the § College of Pharmacy, Seoul National
University, Kwanak-Ku, Seoul 151-742, and the ¶ Department of
Pharmaceutical Analysis, College of Pharmacy, Ewha Womans University,
Seodaemun-Ku, Seoul 120-750, South Korea
It has become evident
that a Ca2+-dependent release of
arachidonic acid (AA) and subsequent formation of bioactive lipid
mediators such as prostaglandins and leukotrienes in red blood cells
(RBCs) can modify physiological functions of neighboring RBCs and
platelets. Here we identified a novel type of cytosolic
PLA2 in bovine and human RBCs and purified it to apparent
homogeneity with a 14,000-fold purification. The purified enzyme,
termed rPLA2, has a molecular mass of 42 kDa and reveals
biochemical properties similar to group IV cPLA2, but shows
different profiles from cPLA2 in several column chromatographies. Moreover, rPLA2 did not react with any of
anti-cPLA2 and anti-sPLA2 antibodies and was
identified as an unknown protein in matrix-assisted laser
desorption/ionization time-of-flight mass spectrometric analysis.
Divalent metal ions tested exhibited similar effects between
rPLA2 and cPLA2, whereas mercurials inhibited cPLA2 but had no effect on rPLA2. Antibody
against the 42-kDa protein not only precipitated the rPLA2
activity, but also reacted with the 42-kDa protein from bovine and
human RBCs in immunoblot analysis. The 42-kDa protein band was
selectively detected in murine fetal liver cells known as a type of
progenitor cells of RBCs. It was found that EA4, a derivative of
quinone newly developed as an inhibitor for rPLA2,
inhibited a Ca2+ ionophore-induced AA release from human
and bovine RBCs, indicating that this enzyme is responsible for the
Ca2+-dependent AA release from mammalian RBCs.
Finally, erythroid progenitor cell assay utilizing diaminobenzidine
staining of hemoglobinized fetal liver cells showed that
rPLA2 detectable in erythroid cells was down-regulated when
differentiated to non-erythroid cells. Together, our results suggest
that the 42-kDa rPLA2 identified as a novel form of
Ca2+-dependent PLA2 may play an
important role in hemostasis, thrombosis, and/or erythropoiesis through
the Ca2+-dependent release of AA.
*
This work was supported by grants from the Ministry of
Commerce, Industry and Energy in Korea, the Korean Science and
Engineering Foundation (Grant 97-04-03-11-01-3), and Brain Korea 21 Program of Ministry of Education and Human Resources Development in
Korea (to D. K. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Environmental & Health Chemistry, College of Pharmacy, Chung-Ang
University, 221 Huksuk-Dong, Dongjak-Ku, Seoul 156-756, South Korea,
Tel.: 82-2-820-5610; Fax: 82-2-816-7338; E-mail:
dkkim@cau.ac.kr.
**
Current address: Renal Division, Medical service, Massachusetts
General Hospital East and Department of Medicine, Harvard Medical
School, Charlestown, MA 02129; E-mail:
hsshin64@hotmail.com.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. A. Lang, D. S. Kempe, V. Tanneur, K. Eisele, B. A. Klarl, S. Myssina, V. Jendrossek, S. Ishii, T. Shimizu, M. Waidmann, et al.
Stimulation of erythrocyte ceramide formation by platelet-activating factor
J. Cell Sci.,
March 15, 2005;
118(6):
1233 - 1243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cipollone, B. Rocca, and C. Patrono
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2004;
24(2):
246 - 255.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|